Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.

Proliferative activity, assessed by Ki67 immunohistochemistry (IHC), is an established prognostic and predictive biomarker of breast cancer (BC). However, it remains under-utilized due to lack of standardized robust measurement methodologies and significant intratumor heterogeneity of expression. A...

Descripción completa

Detalles Bibliográficos
Publicado en:Virchows Archiv: European Journal of Pathology Vol. 468; no. 4; pp. 493 - 503
Autores principales: Laurinavicius, Arvydas, Plancoulaine, Benoit, Rasmusson, Allan, Besusparis, Justinas, Augulis, Renaldas, Meskauskas, Raimundas, Herlin, Paulette, Laurinaviciene, Aida, Abdelhadi Muftah, Abir, Miligy, Islam, Aleskandarany, Mohammed, Rakha, Emad, Green, Andrew, Ellis, Ian, Abdelhadi Muftah, Abir A, Rakha, Emad A, Green, Andrew R, Ellis, Ian O
Formato: pictorial research tables/charts Journal Article
Publicado: Springer Nature Apr2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114514891&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 114514891
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09456317
        O1Z
      jtl: Virchows Archiv: European Journal of Pathology
      issn: 09456317
      maglogo: N
    pubinfo:
      dt: Apr2016
      vid: 468
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        114514891
        114514891
        NLM26818835
        114514891
        10.1007/s00428-016-1907-z
        NLM26818835
        114514891
      ppf: 493
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
      aug:
        au:
          Laurinavicius, Arvydas
          Plancoulaine, Benoit
          Rasmusson, Allan
          Besusparis, Justinas
          Augulis, Renaldas
          Meskauskas, Raimundas
          Herlin, Paulette
          Laurinaviciene, Aida
          Abdelhadi Muftah, Abir
          Miligy, Islam
          Aleskandarany, Mohammed
          Rakha, Emad
          Green, Andrew
          Ellis, Ian
          Abdelhadi Muftah, Abir A
          Rakha, Emad A
          Green, Andrew R
          Ellis, Ian O
        affil: PathImage/BioTICLA, Inserm (UMR 1199), University Caen Normandy, Cancer Center F. Baclesse, Caen France
      sug:
        subj:
          Image Interpretation, Computer Assisted Methods
          Tumor Markers, Biological
          Breast Neoplasms Pathology
          Adult
          Middle Age
          Immunohistochemistry
          Breast Neoplasms Mortality
          Aged
          Neoplasm Invasiveness
          Female
          Prognosis
          Tumor Markers, Biological Analysis
          Cox Proportional Hazards Model
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
      ab: Proliferative activity, assessed by Ki67 immunohistochemistry (IHC), is an established prognostic and predictive biomarker of breast cancer (BC). However, it remains under-utilized due to lack of standardized robust measurement methodologies and significant intratumor heterogeneity of expression. A recently proposed methodology for IHC biomarker assessment in whole slide images (WSI), based on systematic subsampling of tissue information extracted by digital image analysis (DIA) into hexagonal tiling arrays, enables computation of a comprehensive set of Ki67 indicators, including intratumor variability. In this study, the tiling methodology was applied to assess Ki67 expression in WSI of 152 surgically removed Ki67-stained (on full-face sections) BC specimens and to test which, if any, Ki67 indicators can predict overall survival (OS). Visual Ki67 IHC estimates and conventional clinico-pathologic parameters were also included in the study. Analysis revealed linearly independent intrinsic factors of the Ki67 IHC variance: proliferation (level of expression), disordered texture (entropy), tumor size and Nottingham Prognostic Index, bimodality, and correlation. All visual and DIA-generated indicators of the level of Ki67 expression provided significant cutoff values as single predictors of OS. However, only bimodality indicators (Ashman's D, in particular) were independent predictors of OS in the context of hormone receptor and HER2 status. From this, we conclude that spatial heterogeneity of proliferative tumor activity, measured by DIA of Ki67 IHC expression and analyzed by the hexagonal tiling approach, can serve as an independent prognostic indicator of OS in BC patients that outperforms the prognostic power of the level of proliferative activity.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N